Deep Vein Thrombosis and Pulmonary Embolism in Congenital Factor VII Deficiency
- 18 January 1973
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 288 (3) , 141-142
- https://doi.org/10.1056/nejm197301182880309
Abstract
HEREDITARY deficiency of factor VII was first described by Alexander et al. in 1951.1 Factor VII is necessary for the conversion of prothrombin into thrombin in the presence of tissue thromboplastin, and its deficiency is characterized by a prolonged Quick prothrombin time but normal tests of the intrinsic clotting system.2 3 4 It was initially thought that therapeutic anticoagulation with warfarin in the prevention and control of extension of red stasis thrombi was dependent upon achieving a Quick prothrombin time of 20 per cent control. This could often be achieved with high doses of drug on the first day, followed by a . . .Keywords
This publication has 9 references indexed in Scilit:
- Warfarin TherapyNew England Journal of Medicine, 1970
- A clinical and family study of hereditary proconvertin (factor VII) deficiencyThe American Journal of Medicine, 1964
- Congenital deficiency of factor VII (hypoconvertinemia)The American Journal of Medicine, 1964
- Thrombo‐Embolism in Patients with Total Proconvertin (Factor VII) DeficiencyActa Medica Scandinavica, 1962
- THE ANTITHROMBOTIC PROPERTIES OF COUMARIN DRUGSAnnals of Internal Medicine, 1961
- Evidence for an antithrombotic effect of DicumarolAmerican Journal of Physiology-Legacy Content, 1960
- DISAPPEARANCE RATE OF CONCENTRATED PROCONVERTIN EXTRACTS IN CONGENITAL AND ACQUIRED HYPOPROCONVERTINEMIA*Journal of Clinical Investigation, 1960
- Some Observations on the Blood of Patients with‘Factor‐VII’ DeficiencyBritish Journal of Haematology, 1956
- CONGENITAL SPCA DEFICIENCY: A HITHERTO UNRECOGNIZED COAGULATION DEFECT WITH HEMORRHAGE RECTIFIED BY SERUM AND SERUM FRACTIONS 1Journal of Clinical Investigation, 1951